uniQure gains as FDA sets up meeting on gene therapy

uniQure (QURE) added ~14% in the premarket on Friday after the Dutch biotech announced that the U.S. FDA has scheduled a meeting to discuss a marketing application for its gene therapy candidate, AMT-130.
In November, the company disclosed that its plans